Fresenius Medical Care Holdings, Inc. is a wholly-owned subsidiary of Fresenius Medical Care AG & Co. KGaA (“Fresenius”). Listed on both the Frankfurt Stock Exchange (FME) and New York Stock Exchange (FMS), Fresenius is the world’s leading provider of products and services for people with chronic kidney failure. The company is primarily engaged in providing kidney dialysis services and clinical laboratory testing manufacturing and distributing products and equipment for kidney dialysis treatment and providing other medical ancillary services.
Dialysis is a vital blood cleansing procedure that substitutes the function of the kidney in case of kidney failure. During 2014, Fresenius cared for more than 283,000 dialysis patients in 3,349 proprietary clinics in over 45 countries worldwide. Fresenius continues to develop its network of clinics – the largest and most international in the world – to accommodate the ever growing number of dialysis patients. The company also operates more than 40 production sites on all continents, making Fresenius the leading provider of dialysis products including dialysis machines, dialyzers and disposable accessories.